- Home
- DSGN vs ONEG Comparison
DSGN vs ONEG Comparison
Compare DSGN & ONEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- ONEG
- Stock Information
- Founded
- DSGN 2017
- ONEG 2021
- Country
- DSGN United States
- ONEG Hong Kong
- Employees
- DSGN N/A
- ONEG N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- ONEG Homebuilding
- Sector
- DSGN Health Care
- ONEG Consumer Discretionary
- Exchange
- DSGN Nasdaq
- ONEG Nasdaq
- Market Cap
- DSGN 208.9M
- ONEG 181.8M
- IPO Year
- DSGN 2021
- ONEG 2024
- Fundamental
- Price
- DSGN $6.54
- ONEG $11.58
- Analyst Decision
- DSGN
- ONEG
- Analyst Count
- DSGN 0
- ONEG 0
- Target Price
- DSGN N/A
- ONEG N/A
- AVG Volume (30 Days)
- DSGN 173.8K
- ONEG 317.3K
- Earning Date
- DSGN 11-06-2025
- ONEG 01-01-0001
- Dividend Yield
- DSGN N/A
- ONEG N/A
- EPS Growth
- DSGN N/A
- ONEG N/A
- EPS
- DSGN N/A
- ONEG 0.08
- Revenue
- DSGN N/A
- ONEG $53,205,000.00
- Revenue This Year
- DSGN N/A
- ONEG N/A
- Revenue Next Year
- DSGN N/A
- ONEG N/A
- P/E Ratio
- DSGN N/A
- ONEG $158.12
- Revenue Growth
- DSGN N/A
- ONEG N/A
- 52 Week Low
- DSGN $2.60
- ONEG $1.48
- 52 Week High
- DSGN $7.77
- ONEG $13.50
- Technical
- Relative Strength Index (RSI)
- DSGN 54.51
- ONEG 51.92
- Support Level
- DSGN $5.88
- ONEG $11.20
- Resistance Level
- DSGN $7.59
- ONEG $11.79
- Average True Range (ATR)
- DSGN 0.51
- ONEG 0.83
- MACD
- DSGN -0.06
- ONEG -0.12
- Stochastic Oscillator
- DSGN 37.42
- ONEG 48.45
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About ONEG OneConstruction Group Limited Ordinary Shares
OneConstruction Group Ltd is a structural steelwork contractor in Hong Kong. The company is engaged in the procurement and installation of structural steel for construction projects in Hong Kong. Its construction project includes performing site preparatory and preliminary works, developing detailed work schedules and work allocation plans, implementing construction site works, and conducting site safety supervision and quality control.